Analysis10k / Blog
Company Snapshot · UNH

UnitedHealth Group (UNH): What This Company Actually Does

The short answer

UnitedHealth collects insurance premiums to cover people's medical bills, then also owns the clinics, pharmacies, and data services many of those same members use — collecting on both the insurance side and the care-delivery side of the same person's healthcare spending.

Share price
$395.62
Market cap
~$358.4B
FY2025 revenue
$447.6B
Medical care ratio
89.1%

How UnitedHealth makes money

Governments, employers, and individuals pay UnitedHealthcare premiums to cover their medical costs. But a large share of what gets paid out doesn't leave the company: those same members' prescriptions get filled by Optum Rx, their care is often delivered by Optum Health's own clinics and physicians, and their claims are processed using Optum Insight's data and administrative services — so a meaningful portion of every premium dollar flows straight back into the same corporate family.

Government (CMS), employers, individuals
Pay premiums
UnitedHealthcare
Sells insurance
Optum Health, Rx & Insight
Deliver care, fill prescriptions, process claims

Optum bills UnitedHealthcare for the care, drugs, and services it provides to the same members — completing the loop back into premium costs. Source: 10-K FY2025, p.1–3 (Business Overview).

Where the revenue comes from

Revenue by segment — FY2025
SegmentRevenueOperating incomeMargin
UnitedHealthcare (insurance)$344,903M$9,425M2.7%
Optum Rx (pharmacy/PBM)$154,726M$7,193M4.6%
Optum Health (care delivery)$101,957M-$278M-0.3%
Optum Insight (data/admin)$19,417M$2,624M13.5%
Consolidated total$447,567M$18,964M4.2%

Segment revenues include intercompany billing between Optum and UnitedHealthcare, so the four segments sum to more than the consolidated total — that's normal accounting, not an error. Source: 10-K FY2025, p.70–71 (Note 15, Segment Financial Information).

Regional breakdown not disclosedUnitedHealth doesn't publish revenue by country. But 44% of 2025 premium revenue came from the U.S. government (CMS) alone, suggesting the business is overwhelmingly domestic.

Customers and competitors

The end user is an individual member, but the entity actually paying is often the U.S. government: CMS (Medicare) accounted for 44% of premium revenue in 2025, up from 40% in both 2024 and 2023 — an unusually concentrated payer relationship for a company this size.

  • CVS Health (Aetna) — the closest structural match: an insurer (Aetna) paired with a pharmacy benefit manager (Caremark) and retail pharmacy stores.
  • Elevance Health (formerly Anthem) — a Blue Cross Blue Shield-affiliated regional insurer network with a smaller care-delivery footprint than UnitedHealth.
  • Cigna Group — pairs insurance (Cigna Healthcare) with a PBM (Express Scripts), but has a comparatively light direct-care (hospital/clinic) presence.

Source: 10-K FY2025, p.70 (CMS concentration).

The metric that matters most in this sector

The medical care ratio (MCR) shows what share of every premium dollar goes straight back out as medical costs. A rising MCR means less is left over for the insurer — and it's been rising steadily.

Medical care ratio (MCR)
20212022202320242025
82.6%82.0%83.2%85.5%89.1%

A secondary warning sign sits inside Optum Health, which takes on fixed-payment "value-based care" contracts: its operating margin swung from +7.4% in 2024 to -0.3% in 2025 — a sign that cost management on those contracts is currently losing ground, not gaining it.

Source: 10-K FY2025, p.27 (MCR, 2023–2025), p.71 (Optum Health margin); 10-K FY2021, p.27 (2021 MCR).

Leadership and ownership

CEO Stephen J. Hemsley previously ran the company from 2006 to 2017 and returned in May 2025 after Andrew Witty stepped down for personal reasons — an unusual second stint rather than a fresh outside hire. The company's 1977 founders, including Richard Burke, are no longer involved. Insider ownership percentages aren't broken out in the 10-K (proxy-statement confirmation needed).

Source: web search — Healthcare Dive (CEO transition report).

Capital returns

Value
Dividend yield~2.35%
Annual dividend per share$9.28
Payout ratio59.7%
Consecutive years of dividend increases16

Buyback spending has actually fallen — $8,000M (2023) → $9,000M (2024) → $5,545M (2025) — but diluted shares outstanding still dropped 2.9% (938M → 911M) over the same period, meaning the smaller buybacks are still outpacing new share issuance from employee compensation.

Source: web search — stockanalysis.com (dividend data, Aug 2026); 10-K FY2025, p.44 (cash flow), p.30 (share counts).

How this company could fail

Failure scenario If the U.S. government keeps Medicare reimbursement rates growing slower than actual medical costs while simultaneously pursuing a criminal investigation into billing practices, the company loses money on the government business it depends on most — and its credibility with regulators at the same time.
  • Government reimbursement risk — Medicare Advantage payment rates have trailed actual medical-cost growth for several years running, and the medical care ratio has climbed from 82.6% (2021) to 89.1% (2025) as a direct result.
  • Legal and regulatory risk — media reports describe an active U.S. Department of Justice criminal investigation into Medicare Advantage billing practices.
  • Widening Optum Health contract losses — the segment posted a $278M operating loss in 2025 on fixed-payment care contracts, and the company has disclosed that some of these contracts are expected to worsen further in 2026.

Source: 10-K FY2025, p.26–28; web search — CNBC (DOJ investigation report).

Five-year financials

$ millions, calendar years
20212022202320242025
Revenue287,597324,162371,622400,278447,567
YoY growth+12.7%+14.6%+7.7%+11.8%
Operating income (margin)23,970 (8.3%)28,435 (8.8%)32,358 (8.7%)32,287 (8.1%)18,964 (4.2%)
Free cash flow19,88923,40425,68220,70516,075
Total debt46,00357,62362,53776,90478,389
Worth watching2025 revenue rose 11.8%, but operating income fell 41% and margin was cut nearly in half (8.1% → 4.2%). Free cash flow has now declined for two straight years, from a 2023 peak of $25.7B to $16.1B — while total debt has grown 70% since 2021. Net debt/EBITDA jumped from roughly 1.4x (2024) to 2.3x (2025): profit is shrinking at the same time leverage is rising.

Source: 10-K FY2025, p.27 (revenue/operating income 2023–2025), p.40 (debt 2024–2025), p.44 (cash flow); 10-K FY2023, p.25, p.37 (2021–2022 figures); 10-K FY2021, p.40.

What we still don't know

  • When the guidance suspended in May 2025 will resume in full isn't disclosed in these filings — check the most recent earnings call.
  • The scope and likely outcome of the DOJ criminal investigation aren't addressed anywhere in the company's public disclosures.
  • How much further Optum Health's value-based-care losses will grow in 2026 isn't quantified.
Built from UnitedHealth Group's 10-K filings for FY2021, FY2023, FY2024, and FY2025, plus web-search figures (stockanalysis.com, Healthcare Dive, CNBC) for market and news context. This is a research summary, not investment advice — verify against the original filings before acting.

Frequently asked questions

How does UnitedHealth make money?

UnitedHealth collects insurance premiums to cover people's medical bills, then also owns the clinics, pharmacies, and data services many of those same members use — collecting on both the insurance and care-delivery sides of the same person's healthcare spending.

What is a medical care ratio?

The medical care ratio (89.1% here) is the share of premium revenue UnitedHealth pays out in medical claims — the lower it is, the more the insurance side keeps as margin, though a very low ratio can also draw regulatory scrutiny.

What is UnitedHealth's market cap?

As of this article's data, UnitedHealth's market cap was about $358.4B, on FY2025 revenue of $447.6B.